ArticleOncotarget2016

ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.

Anwen Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.